Summary Information:
VistaGen Therapeutics Inc. Common Stock
NASDAQ:VTGN


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


VistaGen Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: VTGN
SEC CIK: 0001411685
Phone: 650-577-3600
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO CA 94080

CEO:
Price when page updated: 3.8011 Date: 2023-12-02
Company Website:
www.vistagen.com

_Description: VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets.

IPO YEAR:

Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
102717270.00
Beta:
0.909649980036633
52 Week High:
3.55
52 Week Low:
1.52
52 Week Change:
0.32666666666666666
Short Interest:

Short Date:

Shares Outstanding:
199702333
Dividend Rate:
0
Dividend Yield:
3.13%
ExDividend Date:

Latest EPS:

Latest EPS Date:
4 Nov 2022
Float:
0
return on Equity:
-23.10%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$758.000M
ttmEPS:
0
Revenue:
$11.018B
Gross Profit:

Cash:

Debt:

Institution Percent:
76.20%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
26.71%
Return on Assets:
-18.10%
Return on Capital:

Profit Margin:
-51.40%
Price to Sales:
5.07
Price To Book:
2.46
Short Ratio:
3.29
PE Ratio:
0
Employees:
21
1Y Guesstimate
0.230:2.0:1




__The following are links to various summary and news pages for
__VistaGen Therapeutics Inc. Common Stock [ VTGN ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-02